6 completed. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 3 | 1 | Completed 1 |
Follow Biorasi, Llc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lomecel-B Effects on Alzheimer's Disease Allogeneic MSC, Placebo - Mild Alzheimer's Disease | Phase 2 | Completed | Longeveron Inc. | 50 | 2021-12-28 | 2024-02-20 |
| Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea Rifaximin, Placebo - Papulopustular Rosacea | Phase 2 | Completed | Alfasigma S.p.A. | 216 | 2021-10-05 | 2024-04-24 |
| B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis B244, Vehicle - Atopic Dermatitis, Pruritus | Phase 2 | Completed | AOBiome LLC | 547 | 2020-06-24 | 2025-01-28 |
| A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) GB0139, Placebo - Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Completed | Galecto Biotech AB | 172 | 2019-02-19 | 2024-05-22 |
| A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea B244, Vehicle - Rosacea | Phase 2 | Completed | AOBiome LLC | 140 | 2018-07-02 | 2022-09-16 |
| Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer Varlitinib, Capecitabine, Placebo (for Varlitinib) - Biliary Tract Cancer | Phase 2 / Phase 3 | Completed | ASLAN Pharmaceuticals | 151 | 2017-07-04 | 2021-08-03 |
Rosacea (2) · Bile Duct Neoplasms (1) · Biliary Tract Neoplasms (1) · Dermatitis, Atopic (1) · Gallbladder Neoplasms (1) · Idiopathic Pulmonary Fibrosis (1) · Neoplasms (1) · Pruritus (1)
ARRY-334543 (1) · Capecitabine (1) · GB-0139 (1) · Rifaximin (1)
United States (6) · Australia (2) · Poland (2) · Spain (2) · Belgium (1) · Canada (1) · China (1) · France (1) · Georgia (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1)
Hyun Kim, PhD (1) · Judith Ng-Cashin, MD (1) · Spiros Jamas, ScD (1) · Toby Maher, MD, PhD (1)
PMID 33072090, PMID 35120836, PMID 37396805, PMID 40065171
2018 (1)